Fécondation in vitro: intérêt et désavantage du remboursement par l'assurance maladie en Suisse [In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland]

Details

Serval ID
serval:BIB_59728BD98A3F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Fécondation in vitro: intérêt et désavantage du remboursement par l'assurance maladie en Suisse [In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland]
Journal
Revue Médicale Suisse
Author(s)
Wunder-Galié D., Hohlfeld P., de Ziegler D.
ISSN
1660-9379
Publication state
Published
Issued date
2009
Volume
5
Number
222
Pages
2106-2108, 2110
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/CSI by the health insurance in Switzerland The reimbursement of certain infertility treatments (stimulation with/without insemination) whereas IVF/ICSI is not leads patients with an indication of IVF to prefer treatments of low efficacy. The costs of multiple pregnancies issued by reimbursed or non-reimbursed fertility treatments are paid by the society. There should be measures to reduce these costs and to take the money used today to pay the complications of infertility treatments to reimburse IVF. The efficacy of such a system (single embryo transfer) has been proven in Belgium since several years. The dangers of complete reimbursement (IVF treatment in cases without any chances of success, only because it is for free) can be avoided by an Efficacy and Safety Board.
Keywords
Fertilization in Vitro/economics, Humans, Insurance Coverage, Reimbursement Mechanisms, Reproductive Techniques, Assisted/economics, Switzerland
Pubmed
Create date
15/02/2010 21:55
Last modification date
20/08/2019 14:12
Usage data